One MedImmune Way
About MedImmune, LLC
MedImmune is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom, and the Netherlands. UK facilities include vaccine manufacturing operations in Speke and antibody discovery and research laboratories in Cambridge.
With two marketed products and an advancing pipeline of promising candidates in the areas of infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience, MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees.
352 articles with MedImmune, LLC
Micromet Achieves Milestone In BiTE™ Research Collaboration With MedImmune, Inc.
MedImmune, Inc. To Build New Biologics Manufacturing Facility In Frederick, Maryland
MedImmune, Inc. Expansion To Create Hundreds Of Jobs
MedImmune, Inc. To Present At The Credit Suisse First Boston 2005 Healthcare Conference
MedImmune, Inc. Reports 2005 Third Quarter And Nine-Month Financial Results
MedImmune, Inc. Further Expands Oncology Pipeline With New Target Based On Innovative Technology From Avidia, Inc.
PreemieCare Growing Number Of Infants At High Risk Of Respiratory Syncytial Virus
U.S. Squeezes Out A Few Million More Flu Vaccines
Biotech Can't Get A Break
Flu Spray Maker Mending After Flop
Atherogenics, Genaera, Pfizer, Genentech, And MedImmune